Merus N.V.

Ownership Transactions Reported by 18 Insiders

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, 3584 Cm Utrecht, Netherlands

Insiders trading volume in the past year

Merus N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bvf Partners L P/Il 10%+ Owner $6.47M Oct 7, 2021
Sven Ante Lundberg President, CEO & PEO, Director $4.87M May 7, 2024
Andrew Joe Svp, Cmo $1.45M May 7, 2024
Peter Silverman Coo & Gc $1.45M -$4.66M -76.3% Jun 27, 2024
Gregory D. Perry Chief Financial Officer & PFO $1.45M May 7, 2024
Hui Liu EVP, CBO & Head of Merus US $1.45M May 7, 2024
Harry Shuman VP Controller, PAO $751K -$1.09M -59.1% Aug 20, 2024
John de Kruif SVP & Chief Technology Officer $744K Jan 31, 2022
Lex Bakker SVP, Chief Development Officer $744K Jan 31, 2022
A. Geuijen Cecile SVP & Chief Scientific Officer $744K Jan 31, 2022
Jason Haddock Director $239K May 7, 2024
Mark T. Iwicki Director $120K May 7, 2024
Paolo Pucci Director $120K May 7, 2024
Maxine Gowen Director $120K May 7, 2024
Len Kanavy Director $120K May 7, 2024
Anand Mehra Director $120K May 7, 2024
Victor Sandor Director $120K May 7, 2024
Fabian Zohren Chief Medical Officer Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Merus N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.